Scholars Central

Conference abstractPublished 23 Sep 2013

Strategy for biosimilar development

Authors: Jichao Jay Kang

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Biosimilar is gaining great traction in the world as it offers expanded accessibility of life-saving biopharmaceuticals, as well as the potential of a lucrative business opportunity. However, unlike the generic pharmaceuticals for small molecules, development of biosimilar is ever challenging and expensive. The presentations will overview the landscape, the general strategy, the workflow, the pitfalls of biosimilar development, with a focus on the analytical tools for protein characterization. Case studies from Laureate?s experience with biosimilar development will be presented.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Bioanalysis & Biomedicine.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Bioanalysis & Biomedicine
  • BylineArticles whose byline prints “Jichao Jay Kang”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels